We are live on !
Find out more
John Rogers Ariel Investments
AUM
$10B
Turnover
14.04%
1-Year Est. Return
42.59%
John W. Rogers Jr. is the founder of Ariel Investments, one of the best-known minority-owned investment firms in the United States. Ariel is associated with patient, value-oriented investing and a long-term “slow and steady” culture. Rogers is also a prominent voice on markets, corporate leadership, and inclusive capitalism.
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+42.59%
3 Year Est. Return
+78.13%
5 Year Est. Return
+79.56%
10 Year Est. Return
+301.99%
AUM
$7.96B
AUM Growth
-$336M
(-4%)
Cap. Flow
-$194M
Cap. Flow % of AUM
Cap. Flow %
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
23.02%
Holding
200
New
6
Increased
83
Reduced
93
Closed
8
Avg Time Held
2.3
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BorgWarner
BWA
|
+$41.7M |
| 2 |
Zebra Technologies
ZBRA
|
+$39.4M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$32.5M |
| 4 |
Nokia
NOK
|
+$30.8M |
| 5 |
HAR
Harman International Industries
HAR
|
+$30.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$63.5M |
| 2 |
U.S. SILICA HOLDINGS, INC.
SLCA
|
+$35.8M |
| 3 |
Southern Company
SO
|
+$29.7M |
| 4 |
AXE
Anixter International Inc
AXE
|
+$23.7M |
| 5 |
Quest Diagnostics
DGX
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.47% |
| 2 | Industrials | 16.17% |
| 3 | Communication Services | 15.56% |
| 4 | Healthcare | 14.47% |
| 5 | Technology | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Kennametal
KMT
$2.21B
| $230M | 2.88% |
10,390,755
-500,143
| -5% | -$11.8M |
2014 Q2
8 quarters
|
|
2
First American
FAF
$6.66B
| $228M | 2.86% |
5,666,824
-314,492
| -5% | -$11.7M |
2013 Q2
12 quarters
|
|
3
Labcorp
LH
$26.3B
| $197M | 2.48% |
1,763,373
-84,293
| -5% | -$9.07M |
2014 Q1
9 quarters
|
|
4
Lazard
LAZ
$3.5B
| $195M | 2.45% |
6,539,522
+57,640
| +0.9% | +$2M |
2013 Q2
12 quarters
|
|
5
DELISTED
Interpublic Group of Companies
IPG
| $182M | 2.29% |
7,893,877
-199,365
| -2% | -$4.68M |
2013 Q2
12 quarters
|
|
6
J.M. Smucker
SJM
$14B
| $178M | 2.23% |
1,167,672
-134,138
| -10% | -$17.8M |
2013 Q2
12 quarters
|
|
7
Northern Trust
NTRS
$30.1B
| $168M | 2.11% |
2,541,852
-7,688
| -0.3% | -$535K |
2013 Q2
12 quarters
|
|
|
AXE
8
DELISTED
Anixter International Inc
AXE
| $155M | 1.94% |
2,905,773
-413,987
| -12% | -$23.7M |
2013 Q2
12 quarters
|
|
9
Baidu
BIDU
$26.7B
| $153M | 1.92% |
928,237
+95,974
| +12% | +$16.9M |
2013 Q2
12 quarters
|
|
10
Zimmer Biomet
ZBH
$18.5B
| $147M | 1.85% |
1,257,618
-55,452
| -4% | -$6.28M |
2013 Q2
12 quarters
|
|
11
DELISTED
TEGNA Inc
TGNA
| $147M | 1.84% |
9,896,963
-782,529
| -7% | -$11.4M |
2013 Q2
12 quarters
|
|
12
Jones Lang LaSalle
JLL
$14.3B
| $143M | 1.79% |
1,464,933
+11,390
| +0.8% | +$1.31M |
2013 Q2
12 quarters
|
|
13
Bio-Rad Laboratories Class A
BIO
$9.8B
| $140M | 1.76% |
980,851
-23,641
| -2% | -$3.37M |
2013 Q2
12 quarters
|
|
14
Western Union
WU
$1.98B
| $134M | 1.68% |
6,989,817
-781,174
| -10% | -$15.2M |
2013 Q2
12 quarters
|
|
15
Aflac
AFL
$60.8B
| $133M | 1.66% |
3,673,578
-251,454
| -6% | -$8.59M |
2013 Q2
12 quarters
|
|
16
KKR & Co
KKR
$82.5B
| $132M | 1.65% |
10,667,131
+367,854
| +4% | +$4.92M |
2013 Q2
12 quarters
|
|
|
ISCA
17
DELISTED
International Speedway Corp
ISCA
| $131M | 1.65% |
3,923,230
-295,445
| -7% | -$9.9M |
2013 Q2
12 quarters
|
|
18
Microsoft
MSFT
$3.9T
| $129M | 1.62% |
2,523,380
+47,608
| +2% | +$2.47M |
2013 Q2
12 quarters
|
|
19
Brady Corp
BRC
$3.88B
| $128M | 1.6% |
4,180,434
-605,858
| -13% | -$17.5M |
2013 Q2
12 quarters
|
|
|
VIAB
20
DELISTED
Viacom Inc. Class B
VIAB
| $127M | 1.59% |
3,055,954
+786,197
| +35% | +$32.5M |
2013 Q2
12 quarters
|
|
21
Mattel
MAT
$4.82B
| $126M | 1.58% |
4,011,191
-408,279
| -9% | -$12.9M |
2015 Q2
4 quarters
|
|
22
Charles River Laboratories
CRL
$16.7B
| $121M | 1.52% |
1,464,130
-202,825
| -12% | -$16.7M |
2013 Q2
12 quarters
|
|
23
Gilead Sciences
GILD
$194B
| $120M | 1.51% |
1,443,305
+82,813
| +6% | +$7.35M |
2013 Q2
12 quarters
|
|
24
Stanley Black & Decker
SWK
$14.6B
| $117M | 1.48% |
1,056,291
-101,512
| -9% | -$11.3M |
2013 Q2
12 quarters
|
|
|
MDP
25
DELISTED
Meredith Corporation
MDP
| $116M | 1.45% |
2,230,110
-52,611
| -2% | -$2.61M |
2013 Q2
12 quarters
|
|
Similar funds
WPL
John Rogers's Q2 2016 Portfolio in Review
As of Q2 2016, John Rogers held 200 positions worth $7.96B, down 4% from $8.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
John Rogers's Q2 2016 filing shows 6 new, 83 increased, 93 reduced and 8 closed positions. Its largest new stake was Emcore Corp: 80,358 shares worth $4.77M. The largest sale was St Jude Medical, an estimated $63.5M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Industrials and Communication Services.
- John Rogers's largest Q2 2016 buy was Emcore Corp: 80,358 shares worth $4.77M.
- John Rogers added most to BorgWarner in Q2 2016, an estimated $41.7M increase.
- John Rogers's biggest Q2 2016 reduction was St Jude Medical, cutting an estimated $63.5M.
- John Rogers fully exited RUCKUS WIRELESS INC COM STK (DE) in Q2 2016, selling an estimated $21.9M.
- John Rogers's ten largest holdings make up 23% of its $7.96B portfolio in Q2 2016.
- John Rogers opened 6 new positions and closed 8 in Q2 2016.
- John Rogers's portfolio value fell 4% quarter-over-quarter to $7.96B.
Based on Ariel Investments's 13F filing for Q2 2016, filed 15 Aug 2016.